Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(23):1685; doi:10.1093/jnci/djj512
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2006.

NEWS

In Brief

Ovary Removal Linked to Higher Death Rates

Premenopausal women who have had their ovaries removed but do not receive adequate hormone replacement therapy have a higher risk of death from several causes, a study shows.

Walter Rocca, M.D., of the Mayo Clinic in Rochester, Minn., and colleagues monitored 1,293 premenopausal women who had one ovary removed, 1,093 premenopausal women who both ovaries removed, and 2,390 controls. The authors found that premenopausal women who had their ovaries removed and did not receive adequate hormone therapy had an increased risk of death from hormone-related cancers and brain or cardiovascular disease. The risk became evident only 10 or more years after the procedure.

The study was published in the October issue of Lancet Oncology.

Study Identifies Genes Associated With Prostate Cancer Risk in African American Men

Several regions of the human genome probably contain genes that, when altered, are linked to prostate cancer risk in African Americans, according to a study from 12 research centers.

Researchers in the African American Hereditary Prostate Cancer study network examined 418 African American men with prostate cancer and their 77 extended families. The researchers used genetic markers to identify areas of the human genome that might contain genes linked to prostate cancer.

The study was published in The Prostate.

NIAID Awards $4 Million For Development of Antiradiation Treatments

The National Institute of Allergy and Infectious Disease awarded five grants totaling $4 million to researchers developing products that eliminate radioactive materials from the body after radiological or nuclear exposure.

If a nuclear explosion occurred, humans could inhale, ingest, or absorb radioactive atoms, which would cause health problems, including cancer. The grant recipients will design drugs that target radioactive atoms and eliminate them from the body.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?